Combining MCMC with ‘sequential’ PKPD modelling

We introduce a method for preventing unwanted feedback in Bayesian PKPD link models. We illustrate the approach using a simple example on a single individual, and subsequently demonstrate the ease with which it can be applied to more general settings. In particular, we look at the three ‘sequential’ population PKPD models examined by Zhang et al. (J Pharmacokinet Pharmacodyn 30:387–404, 2003; J Pharmacokinet Pharmacodyn 30:405–416, 2003), and provide graphical representations of these models to elucidate their structure. An important feature of our approach is that it allows uncertainty regarding the PK parameters to propagate through to inferences on the PD parameters. This is in contrast to standard two-stage approaches whereby ‘plug-in’ point estimates for either the population or the individual-specific PK parameters are required.

[1]  W. K. Hastings,et al.  Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .

[2]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data , 1988 .

[3]  David J. Lunn,et al.  Bayesian Analysis of Population Pharmacokinetic/Pharmacodynamic Models , 2005 .

[4]  David J. Spiegelhalter,et al.  Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  Leon Aarons,et al.  A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  David J. Spiegelhalter,et al.  Bayesian graphical modelling: a case‐study in monitoring health outcomes , 2002 .

[7]  Peter E. Rossi,et al.  Case Studies in Bayesian Statistics , 1998 .

[8]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[9]  Roderick J. A. Little Regression with Missing X's: A Review , 1992 .

[10]  Amy Racine-Poon,et al.  "The Bayesian approach to population pharmacokinetic/pharmacodynamic modeling". In: Case Studies in Bayesian Statistics (Vol IV), Lecture Notes in Statistics , 1999 .

[11]  Ivelina Gueorguieva,et al.  Diazepam Pharamacokinetics from Preclinical to Phase I Using a Bayesian Population Physiologically Based Pharmacokinetic Model with Informative Prior Distributions in Winbugs , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[12]  Xiao-Li Meng,et al.  Multiple-Imputation Inferences with Uncongenial Sources of Input , 1994 .

[13]  Arthur P. Dempster,et al.  The direct use of likelihood for significance testing , 1997, Stat. Comput..

[14]  Stephen J. Roberts,et al.  Probabilistic Modeling in Bioinformatics and Medical Informatics , 2010 .

[15]  Donald Geman,et al.  Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[16]  David J. Lunn,et al.  Markov Chain Monte Carlo Techniques for Studying Interoccasion and Intersubject Variability: Application to Pharmacokinetic Data , 1997 .

[17]  Thomas M. Ludden,et al.  Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[18]  Jon Wakefield,et al.  Bayesian Analysis of Population PK/PD Models: General Concepts and Software , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[19]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[20]  Jon Wakefield,et al.  An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .

[21]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[22]  David J. Lunn,et al.  The Pharmacokinetics of Saquinavir: A Markov Chain Monte Carlo Population Analysis , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[23]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[24]  Steffen L. Lauritzen,et al.  Independence properties of directed markov fields , 1990, Networks.

[25]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[26]  Gordon Graham,et al.  Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[27]  N. G. Best,et al.  WinBUGS User Manual: Version 1.4 , 2001 .